|
Match
|
Document |
Document Title |
|
|
US20090285896 |
BIOABSORBABLE POLYESTERAMIDES AND USES THEREOF
Novel biodegradable polyesteramides derived from optionally functionalized diacids and optionally functionalized diamines or from compounds having both optionally functionalized acid and optionally...
|
|
|
US20090285895 |
Pharmaceutical Formulation for Regulating the Timed Release of Biologically Active Compounds Based on a Polymer Matrix
A formulation containing a biologically active compound having a structure with hydrogen bonding sites is blended with a polymer having a structure with complementary hydrogen bonding sites, the...
|
|
|
US20090285894 |
MICRO-PARTICLES CONTAINING A 3-D POLYMERIC STRUCTURE
Micro-sized particles having a polymeric structure of cells are provided. Also provided is a method of producing micro-sized particles having a polymeric structure comprising: (1) forming a...
|
|
|
US20090280182 |
Devices for the treatment of wounds and methods and kits therefor
Interpenetrating network hydrogels are described that may be incorporated into wound dressings and/or in implants. The properties of the interpenetrating network hydrogel may be tuned to control an...
|
|
|
US20090274762 |
REHYDRATABLE PHARMACEUTICAL PRODUCT
A pharmaceutical product comprising lyophilised polymer matrix including a biologically active compound, of particular utility for embolisation, having improved rehydration properties is packaged...
|
|
|
US20090274758 |
Solid Composition for Intra-Oral Delivery of Insulin
The invention provides a solid composition for intra-oral delivery of insulin, comprising; insulin; a hydrophilic polymer matrix; and a phospholipid, providing insulin bioavailability of at least 5%.
|
|
|
US20090274746 |
METHODS AND COMPOSITIONS FOR CONTROLLED DELIVERY OF PHYTOCHEMICAL AGENTS
The presently-disclosed subject matter provides compositions and methods for treating a cancer by providing a composition comprising a biocompatible polymeric matrix incorporating an effective...
|
|
|
US20090274745 |
Drug delivery systems based on catonic siloxanyl macromonomers
Matrix controlled diffusion drug delivery systems based on one or more silicon-containing monomers of the general formula:
wherein L, X − , n, R1, R2, R3, R4, R5, R6, R7 and V are as set forth...
|
|
|
US20090274744 |
Drug delivery system based on cationic siloxanyl macromonomers
Matrix controlled diffusion drug delivery systems are described herein which are based on one or more silicon-containing monomers of the general formula:
wherein L, X − , n, R1, R2, R3, R4,...
|
|
|
US20090263484 |
Tissue Engineering Devices and Methods for Luminal Organs
Tissue engineering devices and methods are provided for the reconstruction, repair, augmentation, or replacement of a luminal organ or tissue structure involving the use of a biodegradable polymer...
|
|
|
US20090258062 |
Transdermal Therapeutic System Comprising Active Ingredient Particles and Having Increased Active Ingredient Flux
The invention relates to a transdermal therapeutic system, preferably a transdermal patch, having an active ingredient-containing matrix formed substantially of a water-insoluble base material,...
|
|
|
US20090258060 |
Hydrogel Compositions
Hydrogel compositions are provided (a) that have a continuous hydrophobic phase and a discontinuous hydrophilic phase, (b) that have a discontinuous hydrophilic phase and a continuous hydrophilic...
|
|
|
US20090252799 |
MATERIALS AND METHODS FOR WOUND TREATMENT
The subject invention pertains to materials and methods for stopping or decreasing the blood flow from an open wound or medical or surgical procedure. Compositions of the invention comprise a salt...
|
|
|
US20090252798 |
MATRIX-GEL GRAFT WITHOUT CELLS
A cell-free graft contains (i) a cohesive, scaffold-forming matrix with open porosity containing a biologically and pharmaceutically acceptable material, and (ii) a gel of a biologically and...
|
|
|
US20090252781 |
HYDROGEL POLYMERIC COMPOSITIONS AND METHODS
Some aspects of this disclosure relate to a method of treating an opthalmic disease affecting an eye of a patient comprising forming a covalently-crosslinked hydrogel in situ at a peri-ocular,...
|
|
|
US20090246280 |
Resin Powder Containing Aluminum Salt, Process for Production of the Same, and Resin Composition, Phosphorus Adsorbent, Antibacterial Agent or Antifungal Agent Comprising the Same
An aluminum salt-containing resin powder of the present invention includes: at lest one matrix resin component selected from regenerated collagen, polyvinyl alcohol and carboxymethyl cellulose; and...
|
|
|
US20090246279 |
PARTICLES HAVING HYDROPHOBIC MATERIAL THEREIN
A process for preparing particles having a hydrophobic material therein is disclosed. The process comprises providing a multiple emulsion comprising a first emulsion dispersed in a hydrophobic...
|
|
|
US20090246274 |
PHARMACEUTICAL COMPOSITION 271
The invention concerns pharmaceutical compositions containing a hydrogen sulphate salt of 6-(4-bromo-2-chloro-phenylamino)-7-fluoro-3-methyl-3H-benzoi
midazole-5-carboxylic acid...
|
|
|
US20090238874 |
BIOMIMETIC COMPOSITION REINFORCED BY A POLYELECTROLYTIC COMPLEX OF HYALURONIC ACID AND CHITOSAN
The present invention relates to a three dimensional, malleable cell culture composition and method of forming the same comprising hyaluronic acid, chitosan and a polyelectrolytic complex of...
|
|
|
US20090232891 |
Cell Transport Compositions and Uses Thereof
Compositions and methods have been developed for transporting compounds across membranes with little or no toxicity and, when targeted through the appropriate routes of administration (i.e., lung,...
|
|
|
US20090226507 |
HYDROXIDE-RELEASING AGENTS AS SKIN PERMEATION ENHANCERS
A method is provided for increasing the permeability of skin or mucosal tissue to topically or transdermally administered pharmacologically or cosmeceutically active agents. The method involves use...
|
|
|
US20090220607 |
POLYMERIC COMPOSITIONS AND METHODS OF MAKING AND USING THEREOF
Described herein are polymeric compositions having a polymer residue and a crosslinker residue, wherein the polymer residue is bonded to the crosslinker residue with a moiety formed from a...
|
|
|
US20090220606 |
TREATMENT AND PREVENTION OF ABNORMAL CELLULAR PROLIFERATION
This invention provides a method for inhibiting or preventing the abnormal growth of cells, including transformed cells, by administering an effective amount of O-acylated heparin derivative....
|
|
|
US20090220605 |
BONE MATRIX COMPOSITIONS HAVING NANOSCALE TEXTURED SURFACES
Bone matrix compositions having nanoscale textured surfaces and methods for their production are provided. In some embodiments, bone matrix is prepared for implantation and retains nanoscale...
|
|
|
US20090220604 |
AMINO ACIDS IN MICELLE PREPARATION
Formulations are formed of a diblock copolymer (X—Y) having a hydrophilic block X comprising residues of monomer x, and a hydrophobic block Y comprising residues of monomer y; an additive...
|
|
|
US20090220596 |
Composition and Dosage Form Comprising a Solid or Semi-Solid Matrix
A composition which comprises a solid or semi-solid matrix having at least one active ingredient uniformly dispersed therein, the matrix comprising at least one pharmaceutically acceptable...
|
|
|
US20090220578 |
Hydrogel composition and method for making the same
Disclosed is a hydrogel composition comprising water, a first crosslinked polymer, and a second crosslinked polymer, wherein the first crosslinked polymer comprises poly(ethylene oxide) and the...
|
|
|
US20090214652 |
SOFT TISSUE IMPLANTS AND ANTI-SCARRING AGENTS
Soft tissue implants (e.g., breast, pectoral, chin, facial, lip, and nasal implants) are used in combination with an anti-scarring agent in order to inhibit scarring that may otherwise occur when...
|
|
|
US20090214651 |
PRODUCTION OF POLYURETHANE FOAMS
The invention relates to a process for producing polyurethane foams, by frothing and drying specific polyurethane dispersions.
|
|
|
US20090214650 |
Methods of Treating alcoholism and alcohol related disorders using combination drug therapy and swellable polymers
The current invention provides methods of treating alcohol related disorders by providing a sustained release oral drug dosage form comprising a plurality of solid state drugs i.e., baclofen and...
|
|
|
US20090214623 |
ANISOTROPIC HYDROGELS
The invention relates to an anisotropic hydrogel and a method of producing the anisotropic hydrogel. The hydrogel exhibiting anisotropic properties is poly(vinyl alcohol) produced by preparing a...
|
|
|
US20090214616 |
BIOMATERIALS HAVING NANOSCALE LAYERS AND COATINGS
The invention generally relates to substrates and surfaces having substrates. Generally speaking, the substrates may be thinly layered substrates, and the surfaces may comprise thinly layered...
|
|
|
US20090208579 |
Matrix Type Sustained-Release Preparation Containing Basic Drug or Salt Thereof, and Method for Manufacturing the Same
A matrix type sustained-release preparation and a manufacturing method therefor are provided wherein dissolution with low pH dependence of a basic drug or a salt thereof at the early stage of...
|
|
|
US20090208578 |
Method of tissue repair using a multi-layered matrix
A multi-layered matrix, a method of tissue repair using the same, and multi-layered implant prepared thereof are provided. The multi-layered matrix comprises a first element and a second element...
|
|
|
US20090196928 |
Biocompatible hydrogel compositions
Compositions, instruments, systems, and methods are providing for creating families of materials having diverse therapeutic indications and possessing enhanced biocompatibility. One genus platform...
|
|
|
US20090186061 |
Composition Comprising Polymeric, Water-Insoluble, Anionic Particles, Processes and Uses
The present invention relates to an injectable composition which comprises polymeric, water-insoluble, non-biodegradable, anionic particles, these particles having an irregular shape and a...
|
|
|
US20090181094 |
Molecular Cage for Sustained Release Control of Pharmaceutical and Cosmetic Agents
A method of making and using molecular cages is provided to control the release of molecules entrapped or caged within a caging molecule. The caging molecule may be a polymer, cellulose, or an...
|
|
|
US20090170927 |
FUNCTIONALIZED PHENOLIC COMPOUNDS AND POLYMERS THEREFROM
The present invention relates to compounds of formula I, which are functionalized phenolic compounds, and polymers formed from the same.
|
|
|
US20090169628 |
ARTICLE AND METHOD FOR FOCUSED DELIVERY OF THERAPEUTIC AND/OR DIAGNOSTIC MATERIALS
A microfiber extrudate and delivery process includes a bio-compatible polymer matrix forming a body of the microfiber extrudate, an exogenously excitable material arranged within the body, and an...
|
|
|
US20090169471 |
PARTICLES FOR INJECTION AND PROCESSES FOR FORMING THE SAME
According to an aspect of the invention, injectable particles are provided that include (a) porous polymeric particles that contain at least one type of particle-forming polymer and (b) a...
|
|
|
US20090162439 |
SILK FIBROIN COATING
The present invention is directed to compositions and methods for preventing or inhibiting biofilm formation on a solid substrate comprising an antimicrobial agent and a biofilm-degrading enzyme...
|
|
|
US20090162428 |
Immediate disintegration polyvalent polymeric matrix for modified release solid oral preparations and method of preparation thereof
An immediate disintegrating polymeric matrix for oral administration with modified release is disclosed, obtained without using inert supports such as sugar spheres, comprising particles of active...
|
|
|
US20090162410 |
Process for preparing fine particle dispersion for wood preservation
The present invention provide a method for producing micronized solid particles through a two-step process. The solid particles of the invention comprise metals or metal compounds, especially...
|
|
|
US20090155451 |
ANTIMICROBIAL COATING SYSTEM
An antimicrobial coating system, a film-forming composition, and an antimicrobial film. In some embodiments, the antimicrobial coating system can include a film-forming composition comprising a...
|
|
|
US20090155365 |
Method for remotely controlling a sol-gel transition of hydrogels and method for delivering a drug using the same
The present invention relates to a method for remotely controlling a sol-gel transition of hydrogels and a method for delivering a drug using the same. More specifically, the invention relates to a...
|
|
|
US20090148529 |
Hydrogel Suspension and Manufacturing Process Thereof
The present invention relates to a hydrogel suspension which comprises a fine particle and high molecular weight hydroxypropylmethyl cellulose or methylcellulose, which exhibits high transparency...
|
|
|
US20090148528 |
Material that progressively liberates an active liquid substance by evaporation, and mosquito repellent bracelet incorporating such a material
A material controllingly releases by evaporation a liquid active substance and comprises a polymer material matrix impregnated with a liquid composition. The liquid composition contains a mixture...
|
|
|
US20090148486 |
COMPOSITIONS AND METHODS FOR TREATING PULP INFLAMMATIONS CAUSED BY INFECTION OR TRAUMA
The present disclosed subject matter relates to methods and compositions for restoring a diseased or damaged tooth such that infection is inhibited or eliminated and pulp regeneration is...
|
|
|
US20090142400 |
ANALGESIC COATED MEDICAL PRODUCT
Described are medical products including an analgesic such as lidocaine, bupivicaine, or a mixture thereof. Such medical products can find use in pain relief, particularly after surgery, and can be...
|
|
|
US20090142398 |
NOVEL PHARMACEUTICAL COMPOSITIONS COMPRISING A DISINTEGRATION MATRIX
The present invention relates to a stable pharmaceutical composition comprising a pharmaceutically active substance having poor water solubility dispersed in a pharmaceutically acceptable...
|